Capital, talent, markets.
Click any number for its source. Not investment advice.
- Fund
Fund an outcome contract paid per controlled patient-year in one health system.
Hypertension control
- Fund
Back a low-cost generic GLP-1 supplier for a market where the patent has expired.
Diabetes
- Fund
Fund one radiotherapy or pathology training slot through an existing IAEA or St. Jude program.
Cancer
- Fund
Give to a tobacco control program in a country where absolute user counts are growing.
Cancer
- Fund
Fund one year of essential childhood cancer drugs for a single named hospital partner.
Cancer
- Fund
Fund an independent analysis of stage-shift evidence for one cancer with no screening.
Cancer
- Fund
Cover travel costs for patients enrolling in one cancer center trial program.
Cancer
- Fund
Fund grid-enhancing upgrades on specific constrained lines where a utility has already accepted the study.
Energy abundance
- Fund
Back tools that cut study rework only after one developer confirms engineer hours saved on a real project.
Energy abundance
- Fund
Finance transformer test and winding capacity, measured in units accepted per week, not announcements.
Energy abundance
- Fund
Fund firm clean projects with signed offtake, and track delivered MWh rather than financing raised.
Energy abundance
- Fund
Ask any long-duration storage pitch for delivered cost per MWh from an operating project before investing.
Energy abundance
- Fund
Back a second EGS site outside Utah to test whether the Cape result repeats.
Energy abundance
- Fund
Provide local-currency debt to mini-grid and solar home system operators in sub-Saharan Africa.
Energy abundance
- Fund
Offer first-loss or currency hedges that let private lenders follow development bank money.
Energy abundance
- Fund
Fund connection subsidies tied to verified paying customers six months later, not meters installed.
Energy abundance
- AI infrastructure~$725B in 2026Company guidance via Yahoo Finance
- Energy investment$3.3T in 2025IEA World Energy Investment 2025
- Data center electricity+17% in 2025IEA via Bloomberg Law
- GLP-1 drugs~$63B in 2025DelveInsight market estimate